Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA stinging or burning sensation at the injection site is one of the most commonly reported local reactions to semaglutide. Clinical trial data for Wegovy show that injection-site reactions (including stinging, redness and bruising) occurred in roughly 16% of participants, compared with around 8% on placebo. The sensation is almost always mild, short-lived and manageable with small technique adjustments. As a prescription-only medicine, semaglutide should always be used under clinical supervision, with your prescriber guiding any changes to your routine.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 trial, published in the New England Journal of Medicine, enrolled over 1,900 adults and tracked injection-site reactions systematically throughout its 68-week duration. Local reactions were significantly more common in the semaglutide group than placebo but were almost universally classified as mild or moderate, with very few participants stopping treatment because of them. The NHS medicines page for semaglutide lists injection-site reactions, including redness, bruising and stinging, among the common side effects, those affecting up to 1 in 10 people. What the data make clear is that the reaction is pharmacological and predictable rather than a sign that something has gone wrong. The semaglutide solution itself has a slightly acidic pH, which is a property that helps the molecule remain stable in storage but can activate pain receptors in the skin briefly on injection. Knowing the cause matters because it points directly to the fixes: slower delivery, warmer medicine, and better site rotation.
Temperature is the single factor our prescribers hear mentioned most often when patients describe a burning sensation on injection, and if you want a closer look at why it happens and how to manage it, our page on stinging after Wegovy injection covers the causes and remedies in detail. Semaglutide pens are stored in the fridge, and cold liquid hitting subcutaneous tissue reliably causes more discomfort than medicine at room temperature. Letting the pen sit out for 30 minutes before each weekly dose makes a noticeable difference for most people. Speed is the second factor: a slow, steady press of the injector button gives the tissue time to accommodate the volume, whereas a fast plunge amplifies the sting. Third is site selection, the abdomen, thigh and upper arm all work, but each location has different skin thickness and nerve density, so if one spot consistently stings more than another, rotating to a different area is a straightforward adjustment. You can read more about technique for each location on our guide to the best injection site for semaglutide. The fourth factor is the injection angle: a 90-degree entry into a small pinched fold of skin deposits the medicine subcutaneously rather than intradermally, which is both more comfortable and clinically correct per the patient information leaflet.
Many people clean the skin with an alcohol swab before injecting (which is good practice) but injecting before the alcohol has fully evaporated can sharply amplify the stinging sensation. Thirty seconds of air-drying before the injection is enough. Similarly, a blunt or damaged needle creates more tissue trauma even if the difference is invisible to the eye; using a fresh needle for each injection removes this variable entirely. If you need to replace your pen's needles, a 100-pack of compatible needles is available from our pharmacy. Rotating injection sites across the same anatomical region (not just alternating between the left and right sides of the same spot) gives each area several weeks to recover. Injecting repeatedly into the same few centimetres leads to localised tissue changes that increase discomfort over time and can affect how the medicine is absorbed, and those thinking of trying the upper arm as part of their rotation can find practical guidance on our page about the semaglutide arm injection site. For a detailed walkthrough of setting up the pen correctly before any of these steps, the Wegovy pen setup guide covers the process from cap-off to needle disposal.
Brief stinging that fades within a minute or two and leaves no lasting mark is a normal local reaction. The picture that warrants closer attention is different: redness or warmth that spreads beyond the injection spot, a firm lump that persists for more than a week, or any sign of infection such as increasing pain, discharge or a fever. A persistent lump at the injection site can indicate lipohypertrophy (thickened tissue from repeated injections in one area) and is a reason to review your rotation pattern with your prescriber. Any suspected allergic reaction, including widespread itching, rash or difficulty breathing after injecting, needs urgent medical assessment. The MHRA's Yellow Card scheme is the right channel for reporting any suspected adverse reaction to your medicine; it helps regulators monitor real-world safety signals across the population using these treatments. If you have concerns that sit somewhere between mild nuisance and urgent symptom, speaking to a prescriber is the right move. Patients registered with nume can reach our clinical team seven days a week through our aftercare support. For broader questions about how Wegovy works, our Wegovy overview page covers the treatment in full.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.